3,963 reports of this reaction
1.9% of all METOCLOPRAMIDE HYDROCHLORIDE reports
#9 most reported adverse reaction
ECONOMIC PROBLEM is the #9 most commonly reported adverse reaction for METOCLOPRAMIDE HYDROCHLORIDE, manufactured by ANI Pharmaceuticals, Inc.. There are 3,963 FDA adverse event reports linking METOCLOPRAMIDE HYDROCHLORIDE to ECONOMIC PROBLEM. This represents approximately 1.9% of all 206,778 adverse event reports for this drug.
Patients taking METOCLOPRAMIDE HYDROCHLORIDE who experience economic problem should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ECONOMIC PROBLEM is a less commonly reported adverse event for METOCLOPRAMIDE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to economic problem, the following adverse reactions have been reported for METOCLOPRAMIDE HYDROCHLORIDE:
The following drugs have also been linked to economic problem in FDA adverse event reports:
ECONOMIC PROBLEM has been reported as an adverse event in 3,963 FDA reports for METOCLOPRAMIDE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ECONOMIC PROBLEM accounts for approximately 1.9% of all adverse event reports for METOCLOPRAMIDE HYDROCHLORIDE, making it a notable side effect.
If you experience economic problem while taking METOCLOPRAMIDE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.